SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-24-045738
Filing Date
2024-11-08
Accepted
2024-11-08 07:50:51
Documents
5
Period of Report
2024-11-08

Document Format Files

Seq Description Document Type Size
1 6-K ef20038213_6k.htm 6-K 11445
2 EXHIBIT 99.1 ef20038213_ex99-1.htm EX-99.1 602326
3 EXHIBIT 99.2 ef20038213_ex99-2.htm EX-99.2 402947
4 EXHIBIT 99.3 ef20038213_ex99-3.htm EX-99.3 327789
5 image00001.jpg GRAPHIC 3177
  Complete submission text file 0001140361-24-045738.txt   1350088
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38283 | Film No.: 241438036
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)